Detalhe da pesquisa
1.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007321
2.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
3.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060001
4.
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Am J Hematol
; 99(4): 697-718, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269572
5.
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Am J Hematol
; 98(9): 1465-1487, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357958
6.
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
Am J Hematol
; 98(1): 166-179, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200127
7.
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Am J Hematol
; 98(12): 1829-1837, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665758
8.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869407
9.
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
Hematol Oncol
; 40(4): 491-504, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35368098
10.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
11.
Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.
Eur J Haematol
; 106(2): 250-259, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33135220
12.
Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases.
Am J Hematol
; 96(12): 1580-1586, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453762
13.
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study.
BMC Pulm Med
; 21(1): 96, 2021 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743654
14.
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
Am J Hematol
; 95(12): 1599-1613, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974939
15.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol
; 95(2): 156-166, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721282
16.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816122
17.
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
Blood
; 129(24): 3227-3236, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351937
18.
Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
Haematologica
; 104(12): 2391-2399, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123026
19.
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
Hematol Oncol
; 37(3): 240-252, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013548
20.
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Am J Hematol
; 94(1): 133-143, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281843